Comparing Concurrent and Countercurrent Dialysate Flow in Hemodialysis: A Pilot Study on Hyponatremic Patients
Seminars in Dialysis · 2025
DOI: 10.1111/sdi.70008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Seminars in Dialysis, 2025. Verfasst von Amandeep Singh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Hyponatremia, Renal Dialysis, Acute Kidney Injury, Dialysis Solutions. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
In hyponatremic patients, concurrent dialysate flow during hemodialysis may be an ideal option to mitigate complications such as osmotic demyelination syndrome (ODS).
Methods
Present randomized controlled trial enrolled dialysis‐requiring chronic kidney disease (CKD) and acute kidney injury (AKI) patients with serum sodium levels < 125 mEq/L during January 2020 over 16 months. Hemodynamically unstable patients, as well as those with a history of seizures and neurological conditions, were excluded. All were randomized to concurrent and countercurrent dialysate flow groups during two‐h dialysis session. Hydration status was evaluated by Body Composition Monitor BCMTM and hourly sodium was estimated to guide ultrafiltration. Comparative analysis of sodium correction rates (meq/L/h) during dialysis, neurological deterioration via Mini‐Mental State Examination (MMSE) scores, and ODS during 1 week and 1 month in both groups was done. Two‐way repeated measures ANOVA was used to compare sodium correction trends.
Results
A total of 44 hyponatremic patients of AKI (17.39%), CKD (56.52%) and acute on CKD (26.09%) were randomized to concurrent ( n = 23) and countercurrent ( n = 21) dialysate groups. Postdialysis sodium correction rate was nonsignificantly slower in the concurrent group (45.45%) vs. the countercurrent group (36.36% group, p = 0.44). Neurological deterioration, measured via MMSE scores, and ODS incidence were absent in both groups. The concurrent group exhibited a higher proportion of patients without neurological deterioration (73.91%) compared to the countercurrent group (57.14%, p = 0.241). Comparable survival between the two groups was seen at 10, 20, and 30 days. No significant risk factors for mortality were identified in either group.
Conclusion
Concurrent dialysate flow demonstrates a slower but nonsignificant rate of sodium correction, making it a safer alternative for managing severe hyponatremia during hemodialysis by reducing the risk of rapid neurological shifts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
ORCID-Profile: Himansu Sekhar Mahapatra, Manoj Prabhakaran
Zitieren
APA
Singh, A., Pursnani, L., Mahapatra, H. S., Balakrishna, M., Patil, S., Prabhakaran, M., Gautam, A., & Chakraborty, A. (2025). Comparing Concurrent and Countercurrent Dialysate Flow in Hemodialysis: A Pilot Study on Hyponatremic Patients. Seminars in Dialysis. https://doi.org/10.1111/sdi.70008
Vancouver
Singh A, Pursnani L, Mahapatra HS, Balakrishna M, Patil S, Prabhakaran M, et al. Comparing Concurrent and Countercurrent Dialysate Flow in Hemodialysis: A Pilot Study on Hyponatremic Patients. Seminars in Dialysis. 2025. doi:10.1111/sdi.70008
BibTeX
@article{Singh2025,
author = {Singh, Amandeep and Pursnani, Lalit and Mahapatra, Himansu Sekhar and Balakrishna, Muthukumar and Patil, Sanket and Prabhakaran, Manoj and Gautam, Abhishek and Chakraborty, Anubhav},
title = {Comparing Concurrent and Countercurrent Dialysate Flow in Hemodialysis: A Pilot Study on Hyponatremic Patients},
journal = {Seminars in Dialysis},
year = {2025},
doi = {10.1111/sdi.70008}
}
EUVIMED